HPV16 E6/E7 Negatively Affect Radiosensitivity of Lung Cancer Cells

Objective Lung cancer cells associated with radioresistance are likely to give rise to local recurrence and distant metastatic relapse,but little is known about its underlying mechanisms.In the present paper,the effects of the HPV16 E6 and HPV16 E7 oncoprotein on the radiosensitivity of lung cancer cell lines were investigated.Methods The HPV16 E6 or HPV16 E7 oncoprotein was expressed by a transient transfection with pcDNA3-HPV16 E6 or pcDNA3-HPV16 E7 expression vector.Human lung cancer H2179 cells and mouse lung cancer Lewis cells were exposed to a γ-ray radiation source,cellular survival was evaluated by using a colony formation assay.The expression of HPV16 oncoproteins E6/E7,extracellular signal-regulated kinases 1/2(ERK1/2) and AKT signaling was determined by Western blot assay.VEGF secretion was determined by ELISA.Results Both HPV16 oncoproteins E6 and E7 significantly decreased radiosensitivity of H2179 cells,associated with a promotion of the ERK1/2 and AKT phosphorylation.A decrease of reactive oxygen species(ROS) and an increase of VEGF levels were observed in the cells expressing the HPV16 oncoproteins E6 and E7.Furthermore,a similar reduction of radiosensitivity mediated by the HPV16 oncoproteins E6 and E7 was also observed in a mouse lung cancer Lewis cells.Conclusion The findings indicate that the HPV16 oncoproteins E6 and E7 negatively affects susceptibility of lung cancer cells to radiotherapy via regulation of the ERK1/2 and Akt signaling pathway and VEGF expression.     

Profiling EGFR in Triple Negative Breast Tumor Using Affibody PET Imaging

Objective Triple negative breast cancer(TNBC) represents a group of refractory breast cancers with aggressive clinical manifestations as well as poor prognoses.Human epidermal growth factor receptor(EGFR) expression is strongly associated with TNBC progression and it may serve as a therapeutic target for TNBC.We aimed to evaluate EGFR affibody-based PET imaging to profile EGFR expression in small animal models.Methods 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid(DOTA) conjugated Ac-Cys-ZEGFR:1907 was chemically synthesized using solid phase peptide synthesizer and then radiolabeled with 64Cu.The in vitro cell uptake study was performed using SUM159 and MCF7 cells.The biodistribution and small animal PET imaging using 64Cu-DOTA-ZEGFR:1907 were further carried out with nude mice bearing subcutaneous MDA-MB-231 and SUM159 tumors.Results DOTA-Ac-Cys-ZEGFR:1907 was successfully synthesized and radiolabeled with 64Cu.Biodistribution study showed that tumor uptake value of 64Cu-DOTA-Ac-Cys-ZEGFR:1907 remained at(4.07±0.93)％ID/g at 24 h in nude mice(n=4) bearing SUM159 xenografts.Furthermore,small animal PET imaging study clearly showed that 64Cu-DOTA-Ac-Cys-ZEGFR:1907 specifically delineated the EGFR positive TNBC tumors at 4 h or later.Conclusion The study demonstrates that 64Cu-DOTA-Ac-Cys-ZEGFR:1907 is a promising molecular probe for PET imaging of EGFR positive TNBC.EGFR based small protein scaffold holds great promise as a novel platform that can be used for EGFR profiling of TNBC.     

Effect of Amifostine on Patients with Lung Cancer Treated with Radiotherapy or Concomitant Chemoradiotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Objective Amifostine is clinically used as a chemical radioprotector. Nevertheless, its efficacy as a radioprotector remains controversial. Methods PubMed, Cochrane Central Register of Controlled Trials, EMBASE, China National Knowledge Infrastructure, and the references of the published results of trials on the efficacy of amifostine in patients with lung cancer and who received radiotherapy or concomitant chemoradiotherapy were searched. The pooled radiation protection efficacy, treatment response, and side effects of amifostine were calculated using RevMan software. Results Twelve randomized controlled trials involving 1000 patients with lung cancer were ultimately analyzed. Results of meta-analysis revealed that the use of amifostine reduced the risk of acute esophageal toxicity(RR, 0.56; 95% CI, 0.39-0.81; P=0.002) and pulmonary toxicity(RR, 0.42;95% CI, 0.25-0.70;P=0.001). Subgroup analysis also demonstrated that the risk of acute esophageal toxicity and pulmonary toxicity significantly reduced in patients who received chemoradiation concurrent with amifostine or radiation only. Pooled data showed that the use of amifostine did not significantly decrease the risk of late pulmonary toxicity(RR, 0.74; 95% CI, 0.45-1.19; P=0.210). Moreover, subgroup analysis demonstrated that the risk oflate pulmonary toxicity did not significantly decrease in patients who received chemoradiotherapy concomitant with amifostine(RR, 0.84; 95% CI, 0.48-1.46; P=0.540). Amifostine did not exert tumor-protective effects in partial response(RR,0.98;95% CI, 0.83-1.15; P=0.800) but improved complete response(RR, 1.50; 95% CI, 1.03-2.18; P=0.030), although publication bias was observed through Egger' s test(P=0.000). Moreover, amifostine had no effect on one-year overall survival (RR, 0.94; 95% CI, 0.81-1.09; P=0.400) and two-year overall survival(RR, 1.06; 95% CI, 0.81-1.39;P=0.680) rates. The incidence of neutropenia, a hematologic side effect of amifostine, was not significantly different(RR, 1.02; 95% CI, 0.61-1.71; P=0.940) between the amifostine and control group. The use of amifostine, however, significantly decreased the incidence of thrombocytopenia(RR, 0.45;95% CI, 0.21-0.94;P=0.030). The most common amifostine-related side effects were nausea, vomiting, and hypotension with average incidence rates of 11%, 14%, and 24%, respectively. Conclusions This systematic review showed that the concurrent administration of amifostine with radiotherapy to patients with lung cancer significantly reduced the risks of acute esophageal toxicity and acute pulmonary toxicity and decreased the incidence of thrombocytopenia without tumor-protecting effects. In addition, the toxicities of amifostine were generally controllable through clinical treatment or resting.     

Learning From Biomarkers in Victims Accidentally Exposed to Ionizing Radiation

Biomarkers,such as chromosome aberration and micronuclei assays,prove to be reliable for facilitating clinical diagnosis in radiation accidents.In a radiation accident in India,chromosomal aberration,γ-H2AX,as well as other blood markers,were detected in accidentally exposed victims.This multi-parametric approach aided in confirming that individuals had been exposed by ionizing radiation.However,doses were impossible to estimate because of a 30-day delay in accident awareness.Exposure dose for victims was estimated using a dose-response curve previously established.Dose estimation,blood cell depletion kinetics,and no appearance of prodromal symptoms suggested that doses of exposure were low.Hematologic investigation,sampling time,and chromosome aberration scoring were all proposed according to data from the victims exposed to 60Co.Finally,knowledge regarding chromosome aberration analysis and the importance of international co-operation and assistance should be shared from this accident.     

军用食品研究进展

目的 分析和综述国外军用食品研发动态,为研制我军航空航天食品提供参考和思路.资料来源与选择国外该领域的相关研究论文、文章、综述以及美国政府AD报告. 资料引用引用论文、文章和综述以及美国政府AD报告共23篇. 资料综合近年来外军军用食品研究进展很快.通过采用多项高新技术,例如超高压杀菌技术、微波技术、微胶囊包埋技术、食品自加热技术和食品包装新材料.包括高阻隔包装材料与吸收氧气材料有机结合以及食品储存技术的综合应用不断推进军用食品革新.其主要目标是提高食品长时间食用的感官接受性,并改进包装以有效延长食品保质期,使食品更加适合在各种战场环境中食用.此外,研发通过皮肤吸收的营养输送系统等新概念食品为研发军用食品提供了崭新的思路和理念,尽管距离实用阶段还有一段距离.外军军用食品研究新思路体现在给食品赋予抗疲劳和增强免疫力等多种功能性;完善餐谱多样化以满足部队战场多样化需求. 结论 外军将高新技术应用于军用食品研发领域,使军用食品不断改进,主要集中在提高食品接受性、延长贮存期、研发新概念食品、开发自热食品和研制营养模块,并且注重系列化、餐谱化、功能化.这些最新研发动向对我军研制航空航天食品具有借鉴和参考价值. Abstract： Objective To analyze and overview the latest research and development of foreign military rations so as to provide ideas and references to our aviation and space military ration.Literature iesources and selection Foreign theses,research articles,reviews and U.S.government AD reports in the food related fields.Literature quotation Twenty-three pieces of thesis.paper article and review were cited.Literature synthesis The researches of military ration have been rapidly developed in recent years.Many high-technologies,such as ultra-high pressure sterilization technology,microwave technology,microcapsule embedding technology,self-heating ration technology and new food packing materials,including high-separating packing materials,oxygenabsorbing materials and food storage technology,which brought a great deal of innovations for military food have been adopted.The main aims of these researches are to increase the food acceptance for long time consumption.upgrade packing to prolong the shelf life in order to make rations more suitable to eat in different battle-field environments.Moreover,although it still needs time to step in practical application,but researching on new concept ration,such as delivery system of the nutrients under subcutaneous,is providing brand-new idea for military ration research and development.The new research of military ration also focused on food functions,such as anti-fatigue and immune enhancing function,and the development of more food menus to guarantee the military requirement in different battle fields. Conclusions High technologies have been used in military ration development to constantly improve its applicability.The main research issues have been focused on high acceptability,longer shelf life,new concept ration,self-heating ration and nutriment pack.Special attention has been paid to develop more menus to the ration and more special purpose-ration as well as add the components with physiological function to ration.All these information can be used as reference for our development of aviation and space military ration.     

《创伤外科杂志》出版杂志邮寄快速到付的通知

因邮局平邮方式常常发生邮局误丢、误邮事件，故从2015年7月开始，在《创伤外科杂志》发表文章的作者均赠送2本杂志（内附版面费发票），邮寄方式一律采用快递到付的形式（邮资由作者支付）。来稿请附作者姓名、单位省市名称和邮编、详细通讯地址、电话、email。     

武警浙江总队医院30年帮困奏响和谐强音

本刊讯 武警浙江总队医院在认真做好部队官兵医疗保障的同时,连续30年开展为驻地困难家庭送温暖、送健康、献爱心活动,赢得了群众高度赞誉.今年春节前夕,该院在去年帮扶310户困难家庭的基础上,进一步加大了帮扶力度,出资22万余元,对嘉兴市区410户困难家庭开展献爱心行动.     

竹笋味美又疗疾

竹笋,即竹的嫩芽茎,古人称之为"竹肉"、"竹胎"、"竹芽"。竹笋可分为冬笋、春笋、鞭笋3类:冬季藏在土中的为冬笋,色泽洁白,肉质细嫩,鲜美无比,有"笋中皇后"之誉;春天     

补充维生素B2对急性低氧暴露小鼠血浆代谢组的影响

目的 观察补充维生素B2对急性低氧暴露小鼠外周血代谢组的影响.方法 采用随机数字表法将35只雄性昆明小鼠随机分为:正常对照组,低氧对照组,2倍、4倍及8倍维生素B2补充组,每组7只.以相应饲料(维生素B2含量分别为6 mg/kg、12 mg/kg、24 mg/kg和48 mg/kg)喂养2周后,除正常对照组外,其它各组均在模拟6000 m高度停留8 h,采集血浆,以核磁共振的方法分析其代谢组变化.结果 急性低氧暴露后,各组动物血浆代谢组在得分图中呈聚类型分布,且有先分离后同归的代谢模式变化轨迹,显示出补充不同剂量维生素B2后小鼠血浆代谢组逐渐恢复的趋势.代谢模式产生差别的原因是脂类、乳酸、丙氨酸、N-乙酰糖蛋白、谷氨酸、胆碱、牛磺酸、糖、肉碱、甘氨酸和肌酐等物质的水平发生了变化,表明相关的代谢途径发生了变化.结论 补充维生素B2使急性低氧暴露机体碳水化合物、脂肪、蛋白质代谢发生改变,而维生素B2可以改善碳水化合物代谢,并可能通过肉碱间接调节了脂肪代谢;同时还发现一些氨基酸代谢发生显著变化. Abstract： Objective To observe the effects of vitamin B2 supplementation on plasma metabonome of the mice which exposed to acute hypoxia. Methods Thirty-five male Kunming mice were randomly and averagely divided into 5 groups, among which the control and hypoxia control groups were fed the fodder containing 6, 12, 24, 48 mg/kg vitamin B2 respectively. All groups were exposed to simulated hypoxia environment (equivalent to 6000 meters above sea level) for 8 hours except control group. Nuclear magnetic resonance spectrometer was used to test the change of metabonome from collected plasma. Results After acute hypoxia exposure, the metabonome pattern in all groups showed clustering distribution in scores plot and the metabonome changes were along the trail from segregation to regression. These indicated a gradual recover tendency on plasma metabonome when different doses of vitamin B2 supplemented. The changes of lipids, lactic acid,alanine, N-acetyl-glycoprotein (NAC), glutamate, choline, taurine, glucose, carnitine, glycine and creatinine were among the factors contributing significantly to the difference of metabonome pattern and indicated the changes of related metabolic pathway. Conclusions The metabonomes of carbohydrate, lipid and protein of acute hypoxia mice are improved by vitamin B2 supplementation.Vitamin B2 is helpful to improve carbohydrate metabolism and indirectly accommodate lipid metabolism through carnitine. Vitamin B2 supplementation also results in the significant change of amino acid metabonome.